Ginkgo Bioworks Holdings (DNA) Net Shares Issued and Repurchased (2021 - 2023)

Ginkgo Bioworks Holdings (DNA) has reported Net Shares Issued and Repurchased for 3 consecutive years, with $3.9 million the latest figure, recorded in Q1 2023.

• For the quarter ending Q1 2023, Net Shares Issued and Repurchased rose 189.93% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2023 stood at $3.9 million (up 189.93% YoY), and the FY2022 full-year result was $922227.0, down 44.59% from the prior year.
• Net Shares Issued and Repurchased climbed to $3.9 million in Q1 2023 per DNA's latest filing, from $922227.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $3.9 million in Q1 2023 and bottomed at $922227.0 in Q4 2022.
• Historically, Net Shares Issued and Repurchased has averaged $2.0 million across 3 years, with a median of $1.5 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Net Shares Issued and Repurchased sank 44.59% in 2022, then soared 189.93% in 2023.
• Over 3 years, Net Shares Issued and Repurchased stood at $1.7 million in 2021, then tumbled by 44.59% to $922227.0 in 2022, then surged by 325.17% to $3.9 million in 2023.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $3.9 million, $922227.0, and $1.4 million for Q1 2023, Q4 2022, and Q1 2022 respectively.